De novo and recurrence of metabolic dysfunction-associated fatty liver disease after liver transplantation

Metabolic dysfunction-associated fatty liver disease (MAFLD) is a new acronym adopted from the consensus of international experts. Given the increasing prevalence of MAFLD in pre-transplant settings, de novo and recurrent graft steatosis/MAFLD are common in post-transplant settings. The impact of gr...

Descripción completa

Detalles Bibliográficos
Autores principales: Han, Ma Ai Thanda, Olivo, Raquel, Choi, Catherine J, Pyrsopoulos, Nikolaos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2021
Materias:
Minireviews
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8727208/
https://www.ncbi.nlm.nih.gov/pubmed/35070003
http://dx.doi.org/10.4254/wjh.v13.i12.1991

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8727208/
https://www.ncbi.nlm.nih.gov/pubmed/35070003
http://dx.doi.org/10.4254/wjh.v13.i12.1991

Ejemplares similares